Vascular diseases have high incidence, disability and mortality rates. Endovascular treatment is an important option as an alternative to open surgery, with the proven ability to counter severe pathologies. China-based research into vascular diseases and endovascular surgery has been proceeding apace. Endovascology presents, for the first time, the latest research, clinical outcomes, and research frontiers from one of the leading institutes in China specializing in endovascular surgery the Vascular Surgery Department of Changhai Hospital. Specifically, in this book, chapters cover each aspect of vascular disease: Vascular heart disease; Congenital heart disease; Arteriosclerotic heart disease; Thoracic aortic pathology; Thoracoabdominal aortic pathology; Infrarenal abdominal aortic pathology; Cerebral perfusion arteries; Upper limb vessels; Abdominal visceral arteries; Iliac artery; Lower limb artery; Varicose veins; Deep venous thrombosis of the lower limb; Pelvic congestion syndrome; Inferior vena cava and portal vein; Pulmonary artery; and Lymphatic diseases. Endovascology: Endovascular Treatment of Vascular Systematic Pathologies presents a global medical audience with an ambitious, systematic and exhaustive review of vascular diseases, and the state-of-the art in clinical research and practice in endovascology. It will be of use to surgeons, trainees in minimally invasive cardiovascular techniques, vascular disease researchers, and medical students alike. Gives an international audience access to many years of research and practice in endovascular techniques, including clinical outcomes, from clinicians at the Vascular Surgery Department of Changhai Hospital, a pre-eminent institute in China Offers an exhaustive survey of vascular diseases including the history of their treatment, current practices, and potential future developments Presents the latest research, clinical results, and research frontiers from one of China&s leading vascular surgery departments Looks to the future of new endovascular interventions and technologies, encouraging innovation in the treatment of vascular disease